Literature DB >> 24715518

Development of evidenced-based guidelines for PCOS and implications for community health.

Marie Misso1, Jacqueline Boyle1, Robert Norman2, Helena Teede1.   

Abstract

Despite the prevalence and health implications of polycystic ovary syndrome (PCOS), key evidence practice gaps exist including delayed diagnosis, inconsistent management, inadequate support for lifestyle change, and limited attention to psychological and metabolic features. Key contributors to these gaps include a lack of awareness and absence of evidence-based guidelines (EBGs) to inform consumers and health professionals. Intervention was needed to improve awareness, patient experience, early diagnosis, self-management, complication screening, and treatment across reproductive, metabolic, and psychological features driving the authors to establish a national PCOS Alliance. All relevant stakeholders including consumers, researchers, and clinicians codeveloped a vision and based on compellingly need and lobbying, the Australian government funded development of EBGs meeting international standards. To maximize impact, a national dissemination and implementation program was delivered with ongoing evaluation. Activities were recognized by the U.S. National Institute of Health and are being scaled up with the World Health Organization. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 24715518     DOI: 10.1055/s-0034-1371095

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  6 in total

1.  Worldwide Dissatisfaction With the Diagnostic Process and Initial Treatment of PCOS.

Authors:  Melanie Cree-Green
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

2.  Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome.

Authors:  Melanie Gibson-Helm; Helena Teede; Andrea Dunaif; Anuja Dokras
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

3.  The Effects of Probiotics or Synbiotics Supplementation in Women with Polycystic Ovarian Syndrome: a Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Javad Heshmati; Farnaz Farsi; Somaye Yosaee; Maryam Razavi; Mahroo Rezaeinejad; Elham Karimie; Mahdi Sepidarkish
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

Review 4.  Contemporary approaches to the management of polycystic ovary syndrome.

Authors:  Renato Pasquali
Journal:  Ther Adv Endocrinol Metab       Date:  2018-02-07       Impact factor: 3.565

Review 5.  Poly Cystic Ovarian Syndrome: An Updated Overview.

Authors:  Samer El Hayek; Lynn Bitar; Layal H Hamdar; Fadi G Mirza; Georges Daoud
Journal:  Front Physiol       Date:  2016-04-05       Impact factor: 4.566

6.  Elevated androstenedione in young adult but not early adolescent prenatally androgenized female rats.

Authors:  Ami B Shah; Isaac Nivar; Diana L Speelman
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.